Back

Identifying novel small molecule integrin agonists to mimic the favourable effects of the RGD domain of IGFBP-1 to treat cardiometabolic disease

13 April 2024 (08:30 - 17:40)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Drugs, Drug Targets CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2024 Council on Basic Cardiovascular Science

About the speaker

Photo
Miss Emily Rosie Rolfe

Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds (United Kingdom of Great Britain & Northern Ireland)

72 More presentations in this session

Presentation thumbnail
Characterization of senescence in human cardiac fibroblasts
Doctor A. Costa (Genoa, IT)
Abstract
Presentation thumbnail
Cardioprotective effect of cemtirestat treatment in male Zucker diabetic fatty rats: a pilot study.
Doctor T. Egan Benova (Bratislava, SK)
Abstract
Presentation thumbnail
Dynamic links between the cardiac intermediate filaments of the cytoskeleton and nucleoskeleton for proper cardiomyocyte differentiation, maturation and reprogramming.
Doctor M. Tsikitis (Athens, GR)
Abstract
Presentation thumbnail
Differential sex-dependent role of lncRNAs in cardiomyopathy
Professor D. Franco (Jaen, ES)
Abstract
Presentation thumbnail
MiR-92b-3p modulates apoptosis in smooth muscle cells through BCL2L11 regulation, unravelling novel therapeutic strategies for unstable plaques.
Mr J. Koester (Halle, DE)
Abstract

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2024

13 April 2024 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Exploring the interactions between cardiomyocytes and endothelial cells to induce cardiac revascularization and regeneration
thumbnail
Congress Presentation
Endothelial insulin-like growth factor-1 signaling regulates vascular barrier function and atherogenesis
thumbnail
Congress Presentation
Targeting alpha 5 beta 1 integrin as a therapeutic strategy to combat right ventricular dysfunction in pulmonary arterial hypertension

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources